Evidence map›Paper›PMID 23643722›Full record

ArticleImmunity2013

A truncated splice-variant of the FcεRIβ receptor subunit is critical for microtubule formation and degranulation in mast cells.

Glenn Cruse, Michael A Beaven, Ian Ashmole, Peter Bradding, Alasdair M Gilfillan, Dean D Metcalfe

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Exon Skipping of FcεRIβ for Allergic Diseases.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Impaired Proliferation of CD8Journal of immunology research · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasms.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  10. Dermal Extracellular Matrix-Derived Hydrogels as anTissue engineering. Part A · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in genetics · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Glenn CruseLaboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. glenncruse@hotmail.com
Michael A Beaven
Ian Ashmole
Peter Bradding
Alasdair M Gilfillan
Dean D Metcalfe
National Institutes of Health · USUniversity of Leicester · GB

Funding

Integrated Signaling Pathways for the Enhancement of Mast Cell ActivationZIAAI000965 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI METCALFE, DEAN D · 2009 to 2018
$5.3M
Intramural NIH HHS Z99 AI999999NIAID NIH HHS Y99 AI999999
6 · The paper itself

Abstract

Human linkage analyses have implicated the MS4A2-containing gene locus (encoding FcεRIβ) as a candidate for allergy susceptibility. We have identified a truncation of FcεRIβ (t-FcεRIβ) in humans that contains a putative calmodulin-binding domain and thus, we sought to identify the role of this variant in mast cell function. We determined that t-FcεRIβ is critical for microtubule formation and degranulation and that it may perform this function by trafficking adaptor molecules and kinases to the pericentrosomal and Golgi region in response to Ca2+ signals. Mutagenesis studies suggest that calmodulin binding to t-FcεRIβ in the presence of Ca2+ could be critical for t-FcεRIβ function. In addition, gene targeting of t-FcεRIβ attenuated microtubule formation, degranulation, and IL-8 production downstream of Ca2+ signals. Therefore, t-FcεRIβ mediates Ca2+ -dependent microtubule formation, which promotes degranulation and cytokine release. Because t-FcεRIβ has this critical function, it represents a therapeutic target for the downregulation of allergic inflammation.

Indexed as

Adaptor Proteins, Signal TransducingCalciumCalcium SignalingCalmodulin-Binding ProteinsCell DegranulationGolgi ApparatusHumansHypersensitivityImmunoglobulin EInterleukin-8Mast CellsMicrotubulesProstaglandin D2Protein IsoformsReceptors, IgERNA InterferenceAdaptor Proteins, Signal TransducingCalciumCalmodulin-Binding ProteinsGAB2 protein, humanImmunoglobulin EInterleukin-8MS4A2 protein, humanProstaglandin D2Protein IsoformsReceptors, IgERNA, MessengerRNA, Small Interfering

Identifiers

PMID23643722
PMCPMC3694348
OpenAlexW2038545269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.